Oruka Therapeutics, Inc. ( ORKA) - Key Metrics
ORKA Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.66 | -$0.53 | -$0.53 |
| 2026Q1 | $0 | -$0.58 | -$0.43 | -$0.43 |
| 2025Q4 | $0 | -$0.54 | -$0.42 | -$0.42 |
| 2025Q3 | $0 | -$0.69 | -$0.49 | -$0.49 |
| 2025Q2 | $0 | -$0.58 | -$0.55 | -$0.55 |
ORKA Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -36.05 |
| 2026Q1 | 0% | -21.14 |
| 2025Q4 | 0% | -14.03 |
| 2025Q3 | 0% | -6.97 |
| 2025Q2 | 0% | -4.83 |
ORKA
Price: $109.69
52 week price:
Earnings Per Share: -2.04 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 7.4 billion